{"id":983229,"date":"2026-07-21T09:38:50","date_gmt":"2026-07-21T13:38:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/"},"modified":"2026-07-21T09:38:50","modified_gmt":"2026-07-21T13:38:50","slug":"okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/","title":{"rendered":"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference"},"content":{"rendered":"
\n

LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq:\u00a0OKYO<\/a>), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced a presentation at the H.C. Wainwright 6th<\/sup> Annual Ophthalmology Virtual Conference being held on Wednesday, July 22, 2026.<\/p>\n

\n Details of the event are as follows: <\/strong>\n <\/p>\n

\n Presenter:<\/strong> Robert J. Dempsey, Chief Executive Officer, Flavio Mantelli MD, PhD, Chief Medical Officer
Date\/Time: <\/strong>Wednesday, July 22, 12:30 PM ET
Location:<\/strong> Virtual
Register to Attend: <\/strong>H.C. Wainwright Registration<\/a><\/p>\n

\n About OKYO<\/strong>
\n Pharma<\/strong>
\n
OKYO Pharma Limited (Nasdaq: OKYO) is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, with ordinary shares listed for trading on the Nasdaq Capital Market. OKYO plans to initiate a global Phase 3 pivotal clinical trial in the second half of this year, enrolling approximately 111 patients to evaluate a single-dose regimen of urcosimod for the treatment of NCP.<\/p>\n

For further information, please visit\u00a0www.okyopharma.com<\/a>.<\/p>\n

\n For further inquiries:<\/strong>\n <\/p>\n

\n OKYO Pharma Ltd<\/strong>
\n
Paul Spencer
Business Development and Investor Relations
+44 (0) 207 495 2379
Email: info@okyopharma.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq:\u00a0OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced a presentation at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference being held on Wednesday, July 22, 2026. Details of the event are as follows: Presenter: Robert J. Dempsey, Chief Executive Officer, Flavio Mantelli MD, PhD, Chief Medical OfficerDate\/Time: Wednesday, July 22, 12:30 PM ETLocation: VirtualRegister to Attend: H.C. Wainwright Registration About OKYO Pharma OKYO Pharma Limited (Nasdaq: OKYO) is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, with ordinary shares listed … <\/p>\n

Continue reading “OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-983229","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq:\u00a0OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced a presentation at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference being held on Wednesday, July 22, 2026. Details of the event are as follows: Presenter: Robert J. Dempsey, Chief Executive Officer, Flavio Mantelli MD, PhD, Chief Medical OfficerDate\/Time: Wednesday, July 22, 12:30 PM ETLocation: VirtualRegister to Attend: H.C. Wainwright Registration About OKYO Pharma OKYO Pharma Limited (Nasdaq: OKYO) is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, with ordinary shares listed … Continue reading "OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-21T13:38:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference\",\"datePublished\":\"2026-07-21T13:38:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/\"},\"wordCount\":198,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/\",\"name\":\"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM=\",\"datePublished\":\"2026-07-21T13:38:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference - Market Newsdesk","og_description":"LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq:\u00a0OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced a presentation at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference being held on Wednesday, July 22, 2026. Details of the event are as follows: Presenter: Robert J. Dempsey, Chief Executive Officer, Flavio Mantelli MD, PhD, Chief Medical OfficerDate\/Time: Wednesday, July 22, 12:30 PM ETLocation: VirtualRegister to Attend: H.C. Wainwright Registration About OKYO Pharma OKYO Pharma Limited (Nasdaq: OKYO) is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, with ordinary shares listed … Continue reading \"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-21T13:38:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference","datePublished":"2026-07-21T13:38:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/"},"wordCount":198,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/","name":"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM=","datePublished":"2026-07-21T13:38:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NTM0NyM3NzE1Mzg0IzIyMDE0NDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/okyo-pharma-to-present-at-the-h-c-wainwright-6th-annual-ophthalmology-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/983229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=983229"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/983229\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=983229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=983229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=983229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}